BioLine RX News

News

Тикер

BLRX.TA

ISIN

IL0011015182

Prihod Neto dobit P/E P/S EBIT Dividenda Direktori poslovanja Akcije Tržišna kapitalizacija Dug Obaveze Kapital AAQS Zaposleni ROE ROA ROCE News Dokumenti

BioLine RX Eulerpool новости

BioLine RX vijesti o dionici

BioLine RX je u fokusu novinara i investitora diljem svijeta. Najnovije BioLine RX vijesti prikupljamo ovdje.

20. март·
Benzinga
Top Wall Street Forecasters Revamp BioLineRx Expectations Ahead Of Q4 Earnings
26. фебруар·
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
23. фебруар·
Benzinga
Arbitrator Issues Final Award To BioLineRx, Denies All Claims By Biokine Therapeutics; Biokine To Pay Expenses And Legal Fees
29. новембар·
Yahoo
BioLine Rx Ltd (BLRX) Q3 2025 Earnings Call Highlights: Strategic Advances Amid Financial ...
25. новембар·
Yahoo
BLRX: Stem Cell Mobilization Presentation at ASH
24. новембар·
Yahoo
BioLineRx Reports Third Quarter 2025 Financial Results and Provides Corporate Update
24. новембар·
SeekingAlpha
BioLineRx Ltd. (BLRX) Q3 2025 Earnings Call Transcript
18. новембар·
Yahoo
BioLineRx to Report Third Quarter 2025 Results on November 24, 2025
17. новембар·
Yahoo
BioLineRx Announces Receipt of USPTO Notice of Allowance for Key Patent Covering GLIX1 for Treating a Broad Range of Cancer Types
30. септембар·
Yahoo
BLRX: A Venture into GBM
29. септембар·
SeekingAlpha
BioLineRx Ltd. (BLRX) Investor Call (Transcript)
29. септембар·
SeekingAlpha
BioLineRx Ltd. - Special Call
14. август·
SeekingAlpha
BioLineRx Ltd. (BLRX) Q2 2025 Earnings Call Transcript
14. август·
Benzinga
Earnings Scheduled For August 14, 2025
3. јул·
Yahoo
H.C. Wainwright Reaffirms Buy on BioLineRx Ltd. (BLRX) After ASCO 2025
17. јун·
Benzinga
Where BioLine Rx Stands With Analysts
9. јун·
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
31. мај·
Yahoo
BioLineRx upgraded to Buy from Hold at JonesResearch
30. мај·
Benzinga
Dow Edges Higher; Dell Shares Fall After Q1 Results
30. мај·
Yahoo
BioLineRx Announces New Pilot Phase Data from Phase 2 Combination Trial of Motixafortide in First-Line Pancreatic Cancer (PDAC) to be Presented at ASCO 2025 Annual Meeting

BioLine RX priopćenja za javnost o dionici

BioLine RX redovito objavljivuje vijesti na web-mjestu tvrtke relevantne za investitore.

18. новембар•
BioLine RX
Biolinerx Reports Third Quarter 2021 Financial Results And Provides Corporate Update
18. август•
BioLine RX
BioLine RX Reports Q2 Loss Per Share Of $0.01
26. мај•
BioLine RX
Biolinerx Reports Q1 2021 Financial Results
4. мај•
BioLine RX
Biolinerx Announces Positive Top-Line Results From Genesis Phase 3 Trial Of Motixafortide In Stem-Cell Mobilization For Autologous Bone Marrow Transplantation In Multiple Myeloma Patients
23. фебруар•
BioLine RX
Biolinerx Reports Year-End 2020 Financial Results
19. јануар•
BioLine RX
Biolinerx Announces $10 Million Bought Deal Offering
16. децембар•
BioLine RX
Biolinerx Announces Final Results From Phase 2A Combat/Keynote-202 Triple Combination Study Of Motixafortide
23. новембар•
BioLine RX
BioLineRx Reports Q3 Loss Per Share $0.02
18. новембар•
BioLine RX
BiolineRx Announces Initiation Of Phase 1B Clinical Trial In Patients With Acute Respiratory Distress Syndrome Secondary To COVID-19 And Other Respiratory Viral Infections
30. октобар•
BioLine RX
Biolinerx Announces Positive Results From Interim Analysis Of Genesis Phase 3 Trial Of Motixafortide In Stem Cell Mobilization
6. август•
BioLine RX
BioLineRx Says On Track To Report Three Significant Data Readouts In Next Few Months
20. мај•
BioLine RX
Bioline Rx Ltd Reports Q1 Loss Per Share Of $0.04
12. март•
BioLine RX
Bioline On Track To Report Data From Triple Combination Arm Of Ongoing Mid-stage Trial In Mid-2020

BioLine RX News 2026

Ova stranica sadrži sve trenutne vijesti, analizu i prensima za BioLine RX akciju (BLRX.TA, ISIN: IL0011015182). To uključuje Eulerpool vijesti, analizu kompanije i službene prenosima. Podaci se redovito ažuriraju kako bi investitorima pružili potpun pregled najnovijih razvoja u BioLine RX.

BioLine RX Akcija

BioLine RX BioLine RX Ltd je globalna biofarmaceutska kompanija specijalizovana za razvoj novih terapija za rak i druge teške bolesti. Kompanija ima sedište u Izraelu, a kancelarije u Sjedinjenim Američkim Državama i Evropi.